A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase.

A case of a 40-year-old female who died of amniotic fluid embolism is presented. This case showed typical histological findings of this syndrome. Postmortem serum of this case showed an elevated tryptase level (67.2ng/ml, normal levels <10ng/ml). Tryptase is a neutral protease of mast cells, and an important indicator of mast cell activation and degranulation. Thus, mast cell activation, a central feature of anaphylaxis, may have been involved in the pathogenetic mechanism of this case.

[1]  A. Patchefsky,et al.  Case report 3 , 1976, Skeletal Radiology.

[2]  W Q Sturner,et al.  Laboratory investigation of deaths due to anaphylaxis. , 1991, Journal of forensic sciences.

[3]  H. Kobayashi,et al.  Immunologic Studies in Presumed Amniotic Fluid Embolism , 2001, Obstetrics and gynecology.

[4]  S. Clark.  New concepts of amniotic fluid embolism: a review. , 1990, Obstetrical & gynecological survey.

[5]  M. Ansari,et al.  Postmortem diagnosis of acute anaphylaxis by serum tryptase analysis. A case report. , 1993, American journal of clinical pathology.

[6]  L. Schwartz,et al.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. , 1989, Journal of Clinical Investigation.

[7]  S. Clark,et al.  Squamous cells in the maternal pulmonary circulation. , 1986, American journal of obstetrics and gynecology.

[8]  E. Turillazzi,et al.  The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase , 1998, International Journal of Legal Medicine.

[9]  H. Kobayashi,et al.  Serological and Immunohistochemical Diagnosis of Amniotic Fluid Embolism , 1998, Seminars in thrombosis and hemostasis.

[10]  L. Schwartz,et al.  Evaluation of human peripheral blood leukocytes for mast cell tryptase. , 1987, Journal of immunology.

[11]  K.,et al.  Tryptase from human pulmonary mast cells. Purification and characterization. , 1981, The Journal of biological chemistry.

[12]  M. D. Benson.  Nonfatal amniotic fluid embolism. Three possible cases and a new clinical definition. , 1993, Archives of family medicine.

[13]  D. Johnson,et al.  Human lung tryptase. Purification and characterization. , 1984, The Journal of biological chemistry.

[14]  E. Turillazzi,et al.  Fatal anaphylactic shock during a fluorescein angiography. , 1999, Forensic science international.

[15]  T. Porter,et al.  Amniotic fluid embolism: analysis of the national registry. , 1995, American journal of obstetrics and gynecology.

[16]  H. S. Earl,et al.  Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. , 1987, The New England journal of medicine.

[17]  Jacob Hs,et al.  Tissue damage caused by activated complement and granulocytes in shock lung, post perfusion lung, and after amniotic fluid embolism: ramifications for therapy. , 1982 .

[18]  D. Seldin,et al.  Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. , 1981, Journal of immunology.

[19]  H. Kobayashi,et al.  A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc. , 1993, American journal of obstetrics and gynecology.

[20]  J. Williams,et al.  Amniotic fluid activates complement. A role in amniotic fluid embolism syndrome? , 1984, The Journal of laboratory and clinical medicine.